Bulletin
Investor Alert
Philip van Doorn

Deep Dive Archives | Email alerts

April 20, 2019, 7:46 a.m. EDT

Corona and Canopy: A mix of beer and pot that could juice your stock portfolio

Constellation Brands is boosting its U.S. beer business while betting that marijuana products will deliver big sales

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Constellation Brands Inc. Cl A (STZ)
  • X
    Canopy Growth Corp. (WEED)
  • X
    Canopy Growth Corp. (CGC)

or Cancel Already have a watchlist? Log In

By Philip van Doorn, MarketWatch


MarketWatch photo illustration/iStockphoto, Constellation Brands
Constellation Brands beat its competitors to the punch by making a large investment in Canopy Growth Corp.

Randy Hare, the director of equity research at Huntington Private Bank in Cincinnati, said Constellation Brands is setting itself apart in the U.S. beer industry by spending money wisely, with long-term returns for shareholders in mind.

Constellation Brands /zigman2/quotes/207737284/composite STZ -1.76% produces beer, wine and liquor in several countries, and its Corona and Modelo beer brands are growing in the U.S., while competitors are suffering. Constellation, based in Victor, N.Y., agreed earlier this month to sell about 30 of its lower-priced wine and spirits brands to E. & J. Gallo Winery for $1.7 billion.

Tapping into a fast-growing industry, Constellation now holds a 36.6% stake in Smiths Falls, Ontario-based Canopy Growth Corp. /zigman2/quotes/202205609/delayed CA:WEED -3.20%   /zigman2/quotes/200603886/composite CGC -3.22% , with warrants that enable it to increase its stake in the largest publicly traded U.S. or Canadian marijuana company to more than 50%. 

Canopy itself has been negotiating a deal for the right to acquire Acreage Holdings /zigman2/quotes/205165963/delayed ACRGF +0.70% when or if the recreational use of marijuana becomes federally legal in the U.S. 

In an interview, Hare said selling part of the low-priced wine business “gives [Constellation] some flexibility to invest in their CBD market.” CBD stands for cannabidiol, a non-psychoactive ingredient in marijuana that’s known as a treatment for seizures, anxiety and pain. CBD-infused products are growing in popularity.

“This is stuff that can show up in a lotion or a drink or anything like that,” said Hare, whose team manages about $17.5 billion for private clients. “They are allowed to sell these products [in the U.S.] because they are not classified as drugs.”

Through its investment in Canopy, Constellation has booked paper gains of 60% just this year. The company also has been able to participate in a growing cannabis product market. Over the long term, there are great possibilities with Canopy as the regulatory environment for recreational marijuana use in the U.S. loosens.

Looking beyond the cannabis business, Hare said Constellation is “the only beer company that can show growth” in the U.S. “The Mexican import market has continued to grow and has been the one bright spot in the U.S. beer industry,” he said.

When asked about craft brewers’ increasing market share, he said: It has not been pressuring Constellation Brands. It is almost a different market. The craft-beer trend has been going on for years, while Constellation has grown their Corona and Modelo imports [from Mexico].”

Beer business

Four publicly traded companies’ brands dominated the list of the top 25 beer brands in the U.S. in 2017, based on the most recent data compiled by the Beer Institute and National Beer Wholesalers Association .

• Constellation Brands’ fiscal 2018 ended Feb. 28. The company said its annual comparable net sales were up 7% while its gross profit was also up 7% and operating income increased 6%. Beer sales for the fiscal year were up 11.6%, while shipment volume was up 9.7% and operating income from beer sales was up 11%.

• Anheuser-Busch InBev SA /zigman2/quotes/209225053/composite BUD +0.68%  reported a 3.2% decline in global sales for 2018, with a 2.3% decline in gross profit. The company estimated that total U.S. beer sales to retailers (“adjusted for the number of selling days”) were down 1.8% in 2018, while estimating that its own adjusted beer sales to U.S. retailers were down 2.7%, with shipment volumes down 2.6%.

• Molson Coors /zigman2/quotes/205165133/composite TAP +2.38%  said net sales for 2018 were down 2.1% from a year earlier, while adjusted gross profit was down 6.4% and operating income was down 4.8%. The company’s U.S. delivery volume was down 3.9% for the year, while deliveries to wholesalers were down 4.4%.

• Heineken NV /zigman2/quotes/206351165/delayed HEINY +0.37%   /zigman2/quotes/205347870/delayed NL:HEIA +0.32% said it’s U.S. beer sales volume declined during 2018. However, net revenue increased by 6.1% and its operating profit was up 6.4%.

/zigman2/quotes/207737284/composite
US : U.S.: NYSE
$ 179.65
-3.21 -1.76%
Volume: 1.85M
Nov. 15, 2019 6:30p
P/E Ratio
46.58
Dividend Yield
1.67%
Market Cap
$34.01 billion
Rev. per Employee
$842,260
loading...
/zigman2/quotes/202205609/delayed
CA : Canada: Toronto
$ 20.29
-0.67 -3.20%
Volume: 2.08M
Nov. 15, 2019 4:23p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$7.06 billion
Rev. per Employee
$150,142
loading...
/zigman2/quotes/200603886/composite
US : U.S.: NYSE
$ 15.33
-0.51 -3.22%
Volume: 8.34M
Nov. 15, 2019 6:30p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$5.33 billion
Rev. per Employee
$115,039
loading...
/zigman2/quotes/205165963/delayed
US : U.S.: OTC
$ 4.30
+0.03 +0.70%
Volume: 426,627
Nov. 15, 2019 3:59p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$2.89 billion
Rev. per Employee
N/A
loading...
/zigman2/quotes/209225053/composite
US : U.S.: NYSE
$ 79.65
+0.54 +0.68%
Volume: 750,607
Nov. 15, 2019 6:30p
P/E Ratio
21.43
Dividend Yield
1.88%
Market Cap
$130.10 billion
Rev. per Employee
$316,102
loading...
/zigman2/quotes/205165133/composite
US : U.S.: NYSE
$ 52.52
+1.22 +2.38%
Volume: 1.83M
Nov. 15, 2019 6:30p
P/E Ratio
74.20
Dividend Yield
4.34%
Market Cap
$11.36 billion
Rev. per Employee
$606,738
loading...
/zigman2/quotes/206351165/delayed
US : U.S.: OTC
$ 51.19
+0.19 +0.37%
Volume: 29,058
Nov. 15, 2019 3:40p
P/E Ratio
27.13
Dividend Yield
1.46%
Market Cap
$58.54 billion
Rev. per Employee
N/A
loading...
/zigman2/quotes/205347870/delayed
NL : Netherlands: Euronext Amsterdam
92.90
+0.30 +0.32%
Volume: 344,274
Nov. 15, 2019 5:35p
P/E Ratio
28.09
Dividend Yield
1.78%
Market Cap
€52.97 billion
Rev. per Employee
N/A
loading...
1 2
This Story has 0 Comments
Be the first to comment
More News In
Investing

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.